Elucidating the specific pharmacological mechanism of motion (MOA) of In a natural way transpiring compounds is often tough. Whilst Tarselli et al. (60) produced the first de novo artificial pathway to conolidine and showcased this Normally occurring compound successfully suppresses responses to both chemically induced and inflammation-derived pain